HighMark Wealth Management LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 323 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.2%.

Quarter-by-quarter ownership
HighMark Wealth Management LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$885
-22.5%
280.0%0.00%0.0%
Q2 2023$1,142
+9.4%
280.0%0.00%0.0%
Q1 2023$1,044
+6.9%
280.0%0.00%0.0%
Q4 2022$977
-51.2%
280.0%0.00%
-50.0%
Q3 2022$2,000
+100.0%
280.0%0.00%
+100.0%
Q2 2022$1,000
-50.0%
280.0%0.00%0.0%
Q1 2022$2,000
-33.3%
280.0%0.00%
-50.0%
Q4 2021$3,000
+200.0%
280.0%0.00%
+100.0%
Q3 2021$1,000280.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Darwin Global Management, Ltd. 1,859,926$301,141,00048.58%
Burrage Capital Management LLC 63,634$10,303,00010.33%
Elmwood Wealth Management, Inc. 67,174$10,876,0005.73%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 300,327$48,626,0004.72%
Discovery Value Fund 929,669$150,523,0004.08%
Ikarian Capital, LLC 294,400$47,667,0003.85%
Ally Bridge Group (NY) LLC 93,127$15,078,0003.75%
GREAT POINT PARTNERS LLC 100,000$16,191,0003.40%
ARK Investment Management 7,684,441$1,244,188,0002.32%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$18,043,0002.30%
View complete list of INTELLIA THERAPEUTICS INC shareholders